Diabeloop SA (Diabeloop) is a medtech company that designs and develops artificial intelligence (AI) based next generation automated insulin delivery system for Type-1 diabetes. The company’s DBLG1, an external medical device is based on a self-learning algorithm hosted in a handset and connected with a continuous glucose measurement system and an insulin patch pump. It calculates and analyzes real time data and provides dose of insulin to administer based on patient’s physiology, history and data entries.
Diabeloop employs YourLoops, a web platform for data visualization which records, stores and shares the patient’s data to healthcare providers. It works in collaboration with Centre for Studies and Research for the Intensification of Diabetes Treatment (CERITD), public medical centers, and CEA-Leti for advancing its products. Diabeloop is headquartered in Grenoble, Auvergne, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Diabeloop employs YourLoops, a web platform for data visualization which records, stores and shares the patient’s data to healthcare providers. It works in collaboration with Centre for Studies and Research for the Intensification of Diabetes Treatment (CERITD), public medical centers, and CEA-Leti for advancing its products. Diabeloop is headquartered in Grenoble, Auvergne, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Diabeloop SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Diabeloop SA Company Overview
- Diabeloop SA Company Snapshot
- Diabeloop SA Pipeline Products and Ongoing Clinical Trials Overview
- Diabeloop SA - Pipeline Analysis Overview
- Diabeloop SA - Key Facts
- Diabeloop SA - Major Products and Services
- Diabeloop SA Pipeline Products by Development Stage
- Diabeloop SA Ongoing Clinical Trials by Trial Status
- Diabeloop SA Pipeline Products Overview
- Automated Insulin Delivery System
- Automated Insulin Delivery System Product Overview
- DBL-4pen
- DBL-4pen Product Overview
- DBL-4pen Clinical Trial
- DBLG1 - Pediatric Version
- DBLG1 - Pediatric Version Product Overview
- Diabeloop SA - Key Competitors
- Diabeloop SA - Key Employees
- Diabeloop SA - Locations And Subsidiaries
- Head Office
- Recent Developments
- Diabeloop SA, Recent Developments
- Mar 21, 2023: Diabeloop Announces Collaboration With Novo Nordisk to Pursue Its Interoperability Strategy With Connected Insulin Pens
- Feb 23, 2023: Diabeloop: Launch of a multi-country clinical study in adolescents and young adults with T1D
- Sep 21, 2022: 12-month real-world achievements for Diabeloop's AID
- Apr 28, 2022: Diabeloop presents new real-life results of DBLG1 system
- Apr 12, 2022: Diabeloop adapts its self-learning, personalized insulin automatization software to be used with insulin pens
- Sep 16, 2021: Diabeloop joins the AACE Corporate Advisory Program, Appoints US Scientific Advisors
- Jun 02, 2021: DBLG1 self-learning algorithm: Easy to use for optimized and personalized T1D management
- Mar 22, 2021: BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management
- Mar 19, 2021: BIOCORP and Diabeloop announce co-development agreement in personalized diabetes management
- Mar 01, 2021: Diabeloop integrates the Accu-Chek Insight insulin pump from Roche into its Automated Insulin Delivery System
- Appendix
- Methodology
- About the Publisher
- Contact the Publisher
- Disclaimer
- Diabeloop SA Pipeline Products and Ongoing Clinical Trials Overview
- Diabeloop SA Pipeline Products by Equipment Type
- Diabeloop SA Pipeline Products by Indication
- Diabeloop SA Ongoing Clinical Trials by Trial Status
- Diabeloop SA, Key Facts
- Diabeloop SA, Major Products and Services
- Diabeloop SA Number of Pipeline Products by Development Stage
- Diabeloop SA Pipeline Products Summary by Development Stage
- Diabeloop SA Ongoing Clinical Trials by Trial Status
- Diabeloop SA Ongoing Clinical Trials Summary
- Automated Insulin Delivery System - Product Status
- Automated Insulin Delivery System - Product Description
- DBL-4pen - Product Status
- DBL-4pen - Product Description
- DBL-4pen - Multicentric Before/After Study to Assess the Efficacy and Safety of DBL-4pen Mobile Application on Glycemic Control in Patients With Type 2 Diabetes
- DBLG1 - Pediatric Version - Product Status
- DBLG1 - Pediatric Version - Product Description
- Diabeloop SA, Key Employees
- Glossary
- Diabeloop SA Pipeline Products by Equipment Type
- Diabeloop SA Pipeline Products by Development Stage
- Diabeloop SA Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bigfoot Biomedical Inc
- DexCom Deutschland GmbH
- Therapixel SA
- Bigfoot Biomedical Inc
- DexCom Deutschland GmbH
- Therapixel SA
